D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 16,554 217 World Ranking 13683 National Ranking 445

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Immune system

Internal medicine, Immunology, Arthritis, Juvenile rheumatoid arthritis and Surgery are his primary areas of study. His study in Rheumatology, Hematopoietic stem cell transplantation, Randomized controlled trial, Etanercept and Autoimmune disease is done as part of Internal medicine. His Immunology study combines topics from a wide range of disciplines, such as Natural killer cell and Synovial fluid.

His work on Macrophage activation syndrome as part of his general Arthritis study is frequently connected to Patient data, thereby bridging the divide between different branches of science. His work deals with themes such as Methotrexate, Systemic-onset juvenile idiopathic arthritis, Cellular immunity, Myeloid and Proinflammatory cytokine, which intersect with Juvenile rheumatoid arthritis. Nico M Wulffraat interconnects Mucopolysaccharidosis and Hazard ratio in the investigation of issues within Surgery.

His most cited work include:

  • Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. (553 citations)
  • Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis (474 citations)
  • Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis (334 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Arthritis, Immunology, Rheumatology and Pediatrics. As a part of the same scientific family, Nico M Wulffraat mostly works in the field of Internal medicine, focusing on Physical therapy and, on occasion, Clinical trial. His Arthritis research is mostly focused on the topic Juvenile rheumatoid arthritis.

The various areas that Nico M Wulffraat examines in his Immunology study include Hematopoietic stem cell transplantation and Transplantation. Nico M Wulffraat works mostly in the field of Rheumatology, limiting it down to concerns involving Systematic review and, occasionally, Rheumatism. His Pediatrics course of study focuses on Alternative medicine and Pediatric rheumatology.

He most often published in these fields:

  • Internal medicine (50.17%)
  • Arthritis (47.18%)
  • Immunology (30.23%)

What were the highlights of his more recent work (between 2018-2021)?

  • Arthritis (47.18%)
  • Internal medicine (50.17%)
  • Rheumatology (27.24%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Arthritis, Internal medicine, Rheumatology, Family medicine and Vaccination. In general Arthritis, his work in Psoriatic arthritis is often linked to Research design linking many areas of study. Nico M Wulffraat merges Internal medicine with Juvenile Arthritis Disease Activity Score in his study.

His Rheumatology research is multidisciplinary, incorporating elements of Worry, Refractory, Oncology, Tocilizumab and Severity of illness. His Family medicine study also includes

  • Quality of life which intersects with area such as Immunodeficiency and Autoimmune disease,
  • Rheumatism that intertwine with fields like Systematic review and Juvenile chronic arthritis,
  • Health professionals that intertwine with fields like Evidence-based practice, Parental refusal and Paediatric patients,
  • Paediatric rheumatology which intersects with area such as Severe acute respiratory syndrome coronavirus 2. His Vaccination study integrates concerns from other disciplines, such as Hepatitis B, Adverse effect, Juvenile dermatomyositis, Disease and Pediatrics.

Between 2018 and 2021, his most popular works were:

  • 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (144 citations)
  • Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study (46 citations)
  • European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. (33 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Immune system

Nico M Wulffraat mainly focuses on Disease, Family medicine, Internal medicine, Vaccination and Arthritis. His studies in Family medicine integrate themes in fields like Rheumatism and Open label. Nico M Wulffraat works in the field of Internal medicine, namely Rheumatology.

His study looks at the relationship between Rheumatology and fields such as Systematic review, as well as how they intersect with chemical problems. His work carried out in the field of Vaccination brings together such families of science as Hepatitis B, Adverse effect and Pediatrics. His studies deal with areas such as Prednisolone, Anakinra, Prospective cohort study and Monoclonal as well as Arthritis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Fabrizio De Benedetti;Hermine I. Brunner;Nicolino Ruperto;Andrew Kenwright.
The New England Journal of Medicine (2012)

744 Citations

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

Nicolino Ruperto;Hermine I. Brunner;Pierre Quartier;Tamás Constantin.
The New England Journal of Medicine (2012)

631 Citations

Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis

Michael Frosch;Anke Strey;Thomas Vogl;Nico M. Wulffraat.
Arthritis & Rheumatism (2000)

511 Citations

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

Nicolino Ruperto;Kevin J. Murray;Valeria Gerloni;Nico Wulffraat.
Arthritis & Rheumatism (2004)

426 Citations

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson.
Arthritis & Rheumatism (2007)

424 Citations

2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative

Angelo Ravelli;Francesca Serena Minoia;Sergio Davi;Anna Carin Horne.
Arthritis & Rheumatism (2016)

407 Citations

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?

Andrew R. Gennery;Andrew R. Gennery;Mary A. Slatter;Mary A. Slatter;Laure Grandin;Pierre Taupin.
The Journal of Allergy and Clinical Immunology (2010)

353 Citations

Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study

Wilco de Jager;Esther P A H Hoppenreijs;Nico M Wulffraat;Lucy R Wedderburn.
Annals of the Rheumatic Diseases (2007)

317 Citations

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

Reinhard A. Seger;Tayfun Gungor;Bernd H. Belohradsky;Stephane Blanche.
Blood (2002)

299 Citations

Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

Hulya Ozsahin;Marina Cavazzana-Calvo;Luigi D Notarangelo;Ansgar Schulz.
Blood (2008)

283 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nico M Wulffraat

Angelo Ravelli

Angelo Ravelli

Istituto Giannina Gaslini

Publications: 154

Alberto Martini

Alberto Martini

University of Genoa

Publications: 126

Johannes Roth

Johannes Roth

University of Münster

Publications: 104

Lucy R. Wedderburn

Lucy R. Wedderburn

University College London

Publications: 92

Andrew R. Gennery

Andrew R. Gennery

Boston Children's Hospital

Publications: 92

Nicolino Ruperto

Nicolino Ruperto

Istituto Giannina Gaslini

Publications: 92

Dirk Foell

Dirk Foell

Boston Children's Hospital

Publications: 82

Rolando Cimaz

Rolando Cimaz

University of Milan

Publications: 60

Alain Fischer

Alain Fischer

Collège de France

Publications: 56

Daniel J. Lovell

Daniel J. Lovell

Cincinnati Children's Hospital Medical Center

Publications: 55

Thomas Vogl

Thomas Vogl

University of Münster

Publications: 54

Fabrizio De Benedetti

Fabrizio De Benedetti

Bambino Gesù Children's Hospital

Publications: 52

Angela Pistorio

Angela Pistorio

Istituto Giannina Gaslini

Publications: 49

Adrian J. Thrasher

Adrian J. Thrasher

University College London

Publications: 44

Paul Veys

Paul Veys

Great Ormond Street Hospital

Publications: 43

Peter A. Nigrovic

Peter A. Nigrovic

Boston Children's Hospital

Publications: 38

Something went wrong. Please try again later.